Setting new standards in information exchange for the pharmaceutical and biotech industry
Immuno-Oncology 360° Announces the Support of Key Partnerships to Present Multiple Views to Advance IO as a Standard of Cancer Treatment
November 19, 2015
We are delighted to announce new partnerships with Cancer Research Institute (CRI), Society of Immunotherapy for Cancer (SITC) and The Association for Cancer Immunotherapy (CIMT) on the 2nd Annual Immuno-Oncology 360° (IO360°) Conference, taking place February 2-3, 2016 at The New York Academy of Medicine, NYC.
The IO360° conference is the only conference combining the most current business, clinical and scientific developments to help accelerate clinical trials and FDA approval in the growing space of cancer immunotherapies.
With the support of CRI, SITC and CIMT, the Immuno-Oncology 360° program will help drive the field of cancer immunotherapy through knowledge sharing and disseminating the most current data, innovative approaches and developments that are changing the way cancer is treated.
For more information regarding Immuno-Oncology 360° visit: http://theconferenceforum.org/conferences/immuno-oncology-360/overview/